BioSig Technologies, Inc. (BSGM)


-0.09 (-7.69%)
Symbol BSGM
Price $1.08
Beta 1.234
Volume Avg. 0.35M
Market Cap 63.307M
Shares () -
52 Week Range 0.251-1.728
1y Target Est -
DCF Unlevered BSGM DCF ->
DCF Levered BSGM LDCF ->
ROE -374.02% Strong Sell
ROA -573.04% Strong Sell
Operating Margin -
Debt / Equity 159.63% Buy
P/E -
P/B 25.23 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest BSGM news

Mr. Kenneth Londoner
Medical Devices
NASDAQ Capital Market

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.